Request for Covid-19 Impact Assessment of this Report
The United States Alpha Synuclein market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Alpha Synuclein market, reaching US$ million by the year 2028. As for the Europe Alpha Synuclein landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Alpha Synuclein players cover AC Immune SA, AFFiRiS AG, BioArctic AB, and Biogen Inc, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Alpha Synuclein market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
AV-1950R
AV-1947D
BAN-0805
BIIB-054
DPC-003
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Multiple System Atrophy
Neurodegenerateive Disease
Lewy Body Dementia
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AC Immune SA
AFFiRiS AG
BioArctic AB
Biogen Inc
Evotec AG
Genmab A/S
H. Lundbeck A/S
ICB International Inc
MedImmune LLC
Neuropore Therapies Inc
nLife Therapeutics SL
Prothena Corp Plc
QR Pharma Inc
reMYND NV
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Alpha Synuclein Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Alpha Synuclein by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Alpha Synuclein by Country/Region, 2017, 2022 & 2028
2.2 Alpha Synuclein Segment by Type
2.2.1 AV-1950R
2.2.2 AV-1947D
2.2.3 BAN-0805
2.2.4 BIIB-054
2.2.5 DPC-003
2.2.6 Others
2.3 Alpha Synuclein Sales by Type
2.3.1 Global Alpha Synuclein Sales Market Share by Type (2017-2022)
2.3.2 Global Alpha Synuclein Revenue and Market Share by Type (2017-2022)
2.3.3 Global Alpha Synuclein Sale Price by Type (2017-2022)
2.4 Alpha Synuclein Segment by Application
2.4.1 Multiple System Atrophy
2.4.2 Neurodegenerateive Disease
2.4.3 Lewy Body Dementia
2.4.4 Others
2.5 Alpha Synuclein Sales by Application
2.5.1 Global Alpha Synuclein Sale Market Share by Application (2017-2022)
2.5.2 Global Alpha Synuclein Revenue and Market Share by Application (2017-2022)
2.5.3 Global Alpha Synuclein Sale Price by Application (2017-2022)
3 Global Alpha Synuclein by Company
3.1 Global Alpha Synuclein Breakdown Data by Company
3.1.1 Global Alpha Synuclein Annual Sales by Company (2020-2022)
3.1.2 Global Alpha Synuclein Sales Market Share by Company (2020-2022)
3.2 Global Alpha Synuclein Annual Revenue by Company (2020-2022)
3.2.1 Global Alpha Synuclein Revenue by Company (2020-2022)
3.2.2 Global Alpha Synuclein Revenue Market Share by Company (2020-2022)
3.3 Global Alpha Synuclein Sale Price by Company
3.4 Key Manufacturers Alpha Synuclein Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Alpha Synuclein Product Location Distribution
3.4.2 Players Alpha Synuclein Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Alpha Synuclein by Geographic Region
4.1 World Historic Alpha Synuclein Market Size by Geographic Region (2017-2022)
4.1.1 Global Alpha Synuclein Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Alpha Synuclein Annual Revenue by Geographic Region
4.2 World Historic Alpha Synuclein Market Size by Country/Region (2017-2022)
4.2.1 Global Alpha Synuclein Annual Sales by Country/Region (2017-2022)
4.2.2 Global Alpha Synuclein Annual Revenue by Country/Region
4.3 Americas Alpha Synuclein Sales Growth
4.4 APAC Alpha Synuclein Sales Growth
4.5 Europe Alpha Synuclein Sales Growth
4.6 Middle East & Africa Alpha Synuclein Sales Growth
5 Americas
5.1 Americas Alpha Synuclein Sales by Country
5.1.1 Americas Alpha Synuclein Sales by Country (2017-2022)
5.1.2 Americas Alpha Synuclein Revenue by Country (2017-2022)
5.2 Americas Alpha Synuclein Sales by Type
5.3 Americas Alpha Synuclein Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Alpha Synuclein Sales by Region
6.1.1 APAC Alpha Synuclein Sales by Region (2017-2022)
6.1.2 APAC Alpha Synuclein Revenue by Region (2017-2022)
6.2 APAC Alpha Synuclein Sales by Type
6.3 APAC Alpha Synuclein Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Alpha Synuclein by Country
7.1.1 Europe Alpha Synuclein Sales by Country (2017-2022)
7.1.2 Europe Alpha Synuclein Revenue by Country (2017-2022)
7.2 Europe Alpha Synuclein Sales by Type
7.3 Europe Alpha Synuclein Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Alpha Synuclein by Country
8.1.1 Middle East & Africa Alpha Synuclein Sales by Country (2017-2022)
8.1.2 Middle East & Africa Alpha Synuclein Revenue by Country (2017-2022)
8.2 Middle East & Africa Alpha Synuclein Sales by Type
8.3 Middle East & Africa Alpha Synuclein Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Alpha Synuclein
10.3 Manufacturing Process Analysis of Alpha Synuclein
10.4 Industry Chain Structure of Alpha Synuclein
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Alpha Synuclein Distributors
11.3 Alpha Synuclein Customer
12 World Forecast Review for Alpha Synuclein by Geographic Region
12.1 Global Alpha Synuclein Market Size Forecast by Region
12.1.1 Global Alpha Synuclein Forecast by Region (2023-2028)
12.1.2 Global Alpha Synuclein Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Alpha Synuclein Forecast by Type
12.7 Global Alpha Synuclein Forecast by Application
13 Key Players Analysis
13.1 AC Immune SA
13.1.1 AC Immune SA Company Information
13.1.2 AC Immune SA Alpha Synuclein Product Offered
13.1.3 AC Immune SA Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AC Immune SA Main Business Overview
13.1.5 AC Immune SA Latest Developments
13.2 AFFiRiS AG
13.2.1 AFFiRiS AG Company Information
13.2.2 AFFiRiS AG Alpha Synuclein Product Offered
13.2.3 AFFiRiS AG Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 AFFiRiS AG Main Business Overview
13.2.5 AFFiRiS AG Latest Developments
13.3 BioArctic AB
13.3.1 BioArctic AB Company Information
13.3.2 BioArctic AB Alpha Synuclein Product Offered
13.3.3 BioArctic AB Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 BioArctic AB Main Business Overview
13.3.5 BioArctic AB Latest Developments
13.4 Biogen Inc
13.4.1 Biogen Inc Company Information
13.4.2 Biogen Inc Alpha Synuclein Product Offered
13.4.3 Biogen Inc Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Biogen Inc Main Business Overview
13.4.5 Biogen Inc Latest Developments
13.5 Evotec AG
13.5.1 Evotec AG Company Information
13.5.2 Evotec AG Alpha Synuclein Product Offered
13.5.3 Evotec AG Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Evotec AG Main Business Overview
13.5.5 Evotec AG Latest Developments
13.6 Genmab A/S
13.6.1 Genmab A/S Company Information
13.6.2 Genmab A/S Alpha Synuclein Product Offered
13.6.3 Genmab A/S Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Genmab A/S Main Business Overview
13.6.5 Genmab A/S Latest Developments
13.7 H. Lundbeck A/S
13.7.1 H. Lundbeck A/S Company Information
13.7.2 H. Lundbeck A/S Alpha Synuclein Product Offered
13.7.3 H. Lundbeck A/S Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 H. Lundbeck A/S Main Business Overview
13.7.5 H. Lundbeck A/S Latest Developments
13.8 ICB International Inc
13.8.1 ICB International Inc Company Information
13.8.2 ICB International Inc Alpha Synuclein Product Offered
13.8.3 ICB International Inc Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 ICB International Inc Main Business Overview
13.8.5 ICB International Inc Latest Developments
13.9 MedImmune LLC
13.9.1 MedImmune LLC Company Information
13.9.2 MedImmune LLC Alpha Synuclein Product Offered
13.9.3 MedImmune LLC Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 MedImmune LLC Main Business Overview
13.9.5 MedImmune LLC Latest Developments
13.10 Neuropore Therapies Inc
13.10.1 Neuropore Therapies Inc Company Information
13.10.2 Neuropore Therapies Inc Alpha Synuclein Product Offered
13.10.3 Neuropore Therapies Inc Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Neuropore Therapies Inc Main Business Overview
13.10.5 Neuropore Therapies Inc Latest Developments
13.11 nLife Therapeutics SL
13.11.1 nLife Therapeutics SL Company Information
13.11.2 nLife Therapeutics SL Alpha Synuclein Product Offered
13.11.3 nLife Therapeutics SL Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 nLife Therapeutics SL Main Business Overview
13.11.5 nLife Therapeutics SL Latest Developments
13.12 Prothena Corp Plc
13.12.1 Prothena Corp Plc Company Information
13.12.2 Prothena Corp Plc Alpha Synuclein Product Offered
13.12.3 Prothena Corp Plc Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Prothena Corp Plc Main Business Overview
13.12.5 Prothena Corp Plc Latest Developments
13.13 QR Pharma Inc
13.13.1 QR Pharma Inc Company Information
13.13.2 QR Pharma Inc Alpha Synuclein Product Offered
13.13.3 QR Pharma Inc Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 QR Pharma Inc Main Business Overview
13.13.5 QR Pharma Inc Latest Developments
13.14 reMYND NV
13.14.1 reMYND NV Company Information
13.14.2 reMYND NV Alpha Synuclein Product Offered
13.14.3 reMYND NV Alpha Synuclein Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 reMYND NV Main Business Overview
13.14.5 reMYND NV Latest Developments
14 Research Findings and Conclusion
Table 1. Alpha Synuclein Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Alpha Synuclein Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of AV-1950R
Table 4. Major Players of AV-1947D
Table 5. Major Players of BAN-0805
Table 6. Major Players of BIIB-054
Table 7. Major Players of DPC-003
Table 8. Major Players of Others
Table 9. Global Alpha Synuclein Sales by Type (2017-2022) & (K Pcs)
Table 10. Global Alpha Synuclein Sales Market Share by Type (2017-2022)
Table 11. Global Alpha Synuclein Revenue by Type (2017-2022) & ($ million)
Table 12. Global Alpha Synuclein Revenue Market Share by Type (2017-2022)
Table 13. Global Alpha Synuclein Sale Price by Type (2017-2022) & (USD/Pcs)
Table 14. Global Alpha Synuclein Sales by Application (2017-2022) & (K Pcs)
Table 15. Global Alpha Synuclein Sales Market Share by Application (2017-2022)
Table 16. Global Alpha Synuclein Revenue by Application (2017-2022)
Table 17. Global Alpha Synuclein Revenue Market Share by Application (2017-2022)
Table 18. Global Alpha Synuclein Sale Price by Application (2017-2022) & (USD/Pcs)
Table 19. Global Alpha Synuclein Sales by Company (2020-2022) & (K Pcs)
Table 20. Global Alpha Synuclein Sales Market Share by Company (2020-2022)
Table 21. Global Alpha Synuclein Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Alpha Synuclein Revenue Market Share by Company (2020-2022)
Table 23. Global Alpha Synuclein Sale Price by Company (2020-2022) & (USD/Pcs)
Table 24. Key Manufacturers Alpha Synuclein Producing Area Distribution and Sales Area
Table 25. Players Alpha Synuclein Products Offered
Table 26. Alpha Synuclein Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Alpha Synuclein Sales by Geographic Region (2017-2022) & (K Pcs)
Table 30. Global Alpha Synuclein Sales Market Share Geographic Region (2017-2022)
Table 31. Global Alpha Synuclein Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Alpha Synuclein Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Alpha Synuclein Sales by Country/Region (2017-2022) & (K Pcs)
Table 34. Global Alpha Synuclein Sales Market Share by Country/Region (2017-2022)
Table 35. Global Alpha Synuclein Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Alpha Synuclein Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Alpha Synuclein Sales by Country (2017-2022) & (K Pcs)
Table 38. Americas Alpha Synuclein Sales Market Share by Country (2017-2022)
Table 39. Americas Alpha Synuclein Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Alpha Synuclein Revenue Market Share by Country (2017-2022)
Table 41. Americas Alpha Synuclein Sales by Type (2017-2022) & (K Pcs)
Table 42. Americas Alpha Synuclein Sales Market Share by Type (2017-2022)
Table 43. Americas Alpha Synuclein Sales by Application (2017-2022) & (K Pcs)
Table 44. Americas Alpha Synuclein Sales Market Share by Application (2017-2022)
Table 45. APAC Alpha Synuclein Sales by Region (2017-2022) & (K Pcs)
Table 46. APAC Alpha Synuclein Sales Market Share by Region (2017-2022)
Table 47. APAC Alpha Synuclein Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Alpha Synuclein Revenue Market Share by Region (2017-2022)
Table 49. APAC Alpha Synuclein Sales by Type (2017-2022) & (K Pcs)
Table 50. APAC Alpha Synuclein Sales Market Share by Type (2017-2022)
Table 51. APAC Alpha Synuclein Sales by Application (2017-2022) & (K Pcs)
Table 52. APAC Alpha Synuclein Sales Market Share by Application (2017-2022)
Table 53. Europe Alpha Synuclein Sales by Country (2017-2022) & (K Pcs)
Table 54. Europe Alpha Synuclein Sales Market Share by Country (2017-2022)
Table 55. Europe Alpha Synuclein Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Alpha Synuclein Revenue Market Share by Country (2017-2022)
Table 57. Europe Alpha Synuclein Sales by Type (2017-2022) & (K Pcs)
Table 58. Europe Alpha Synuclein Sales Market Share by Type (2017-2022)
Table 59. Europe Alpha Synuclein Sales by Application (2017-2022) & (K Pcs)
Table 60. Europe Alpha Synuclein Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Alpha Synuclein Sales by Country (2017-2022) & (K Pcs)
Table 62. Middle East & Africa Alpha Synuclein Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Alpha Synuclein Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Alpha Synuclein Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Alpha Synuclein Sales by Type (2017-2022) & (K Pcs)
Table 66. Middle East & Africa Alpha Synuclein Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Alpha Synuclein Sales by Application (2017-2022) & (K Pcs)
Table 68. Middle East & Africa Alpha Synuclein Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Alpha Synuclein
Table 70. Key Market Challenges & Risks of Alpha Synuclein
Table 71. Key Industry Trends of Alpha Synuclein
Table 72. Alpha Synuclein Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Alpha Synuclein Distributors List
Table 75. Alpha Synuclein Customer List
Table 76. Global Alpha Synuclein Sales Forecast by Region (2023-2028) & (K Pcs)
Table 77. Global Alpha Synuclein Sales Market Forecast by Region
Table 78. Global Alpha Synuclein Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Alpha Synuclein Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Alpha Synuclein Sales Forecast by Country (2023-2028) & (K Pcs)
Table 81. Americas Alpha Synuclein Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Alpha Synuclein Sales Forecast by Region (2023-2028) & (K Pcs)
Table 83. APAC Alpha Synuclein Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Alpha Synuclein Sales Forecast by Country (2023-2028) & (K Pcs)
Table 85. Europe Alpha Synuclein Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Alpha Synuclein Sales Forecast by Country (2023-2028) & (K Pcs)
Table 87. Middle East & Africa Alpha Synuclein Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Alpha Synuclein Sales Forecast by Type (2023-2028) & (K Pcs)
Table 89. Global Alpha Synuclein Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Alpha Synuclein Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Alpha Synuclein Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Alpha Synuclein Sales Forecast by Application (2023-2028) & (K Pcs)
Table 93. Global Alpha Synuclein Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Alpha Synuclein Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Alpha Synuclein Revenue Market Share Forecast by Application (2023-2028)
Table 96. AC Immune SA Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 97. AC Immune SA Alpha Synuclein Product Offered
Table 98. AC Immune SA Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 99. AC Immune SA Main Business
Table 100. AC Immune SA Latest Developments
Table 101. AFFiRiS AG Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 102. AFFiRiS AG Alpha Synuclein Product Offered
Table 103. AFFiRiS AG Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 104. AFFiRiS AG Main Business
Table 105. AFFiRiS AG Latest Developments
Table 106. BioArctic AB Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 107. BioArctic AB Alpha Synuclein Product Offered
Table 108. BioArctic AB Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 109. BioArctic AB Main Business
Table 110. BioArctic AB Latest Developments
Table 111. Biogen Inc Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 112. Biogen Inc Alpha Synuclein Product Offered
Table 113. Biogen Inc Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 114. Biogen Inc Main Business
Table 115. Biogen Inc Latest Developments
Table 116. Evotec AG Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 117. Evotec AG Alpha Synuclein Product Offered
Table 118. Evotec AG Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 119. Evotec AG Main Business
Table 120. Evotec AG Latest Developments
Table 121. Genmab A/S Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 122. Genmab A/S Alpha Synuclein Product Offered
Table 123. Genmab A/S Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 124. Genmab A/S Main Business
Table 125. Genmab A/S Latest Developments
Table 126. H. Lundbeck A/S Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 127. H. Lundbeck A/S Alpha Synuclein Product Offered
Table 128. H. Lundbeck A/S Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 129. H. Lundbeck A/S Main Business
Table 130. H. Lundbeck A/S Latest Developments
Table 131. ICB International Inc Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 132. ICB International Inc Alpha Synuclein Product Offered
Table 133. ICB International Inc Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 134. ICB International Inc Main Business
Table 135. ICB International Inc Latest Developments
Table 136. MedImmune LLC Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 137. MedImmune LLC Alpha Synuclein Product Offered
Table 138. MedImmune LLC Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 139. MedImmune LLC Main Business
Table 140. MedImmune LLC Latest Developments
Table 141. Neuropore Therapies Inc Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 142. Neuropore Therapies Inc Alpha Synuclein Product Offered
Table 143. Neuropore Therapies Inc Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 144. Neuropore Therapies Inc Main Business
Table 145. Neuropore Therapies Inc Latest Developments
Table 146. nLife Therapeutics SL Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 147. nLife Therapeutics SL Alpha Synuclein Product Offered
Table 148. nLife Therapeutics SL Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 149. nLife Therapeutics SL Main Business
Table 150. nLife Therapeutics SL Latest Developments
Table 151. Prothena Corp Plc Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 152. Prothena Corp Plc Alpha Synuclein Product Offered
Table 153. Prothena Corp Plc Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 154. Prothena Corp Plc Main Business
Table 155. Prothena Corp Plc Latest Developments
Table 156. QR Pharma Inc Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 157. QR Pharma Inc Alpha Synuclein Product Offered
Table 158. QR Pharma Inc Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 159. QR Pharma Inc Main Business
Table 160. QR Pharma Inc Latest Developments
Table 161. reMYND NV Basic Information, Alpha Synuclein Manufacturing Base, Sales Area and Its Competitors
Table 162. reMYND NV Alpha Synuclein Product Offered
Table 163. reMYND NV Alpha Synuclein Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 164. reMYND NV Main Business
Table 165. reMYND NV Latest Developments
List of Figures
Figure 1. Picture of Alpha Synuclein
Figure 2. Alpha Synuclein Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Alpha Synuclein Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Alpha Synuclein Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Alpha Synuclein Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of AV-1950R
Figure 10. Product Picture of AV-1947D
Figure 11. Product Picture of BAN-0805
Figure 12. Product Picture of BIIB-054
Figure 13. Product Picture of DPC-003
Figure 14. Product Picture of Others
Figure 15. Global Alpha Synuclein Sales Market Share by Type in 2021
Figure 16. Global Alpha Synuclein Revenue Market Share by Type (2017-2022)
Figure 17. Alpha Synuclein Consumed in Multiple System Atrophy
Figure 18. Global Alpha Synuclein Market: Multiple System Atrophy (2017-2022) & (K Pcs)
Figure 19. Alpha Synuclein Consumed in Neurodegenerateive Disease
Figure 20. Global Alpha Synuclein Market: Neurodegenerateive Disease (2017-2022) & (K Pcs)
Figure 21. Alpha Synuclein Consumed in Lewy Body Dementia
Figure 22. Global Alpha Synuclein Market: Lewy Body Dementia (2017-2022) & (K Pcs)
Figure 23. Alpha Synuclein Consumed in Others
Figure 24. Global Alpha Synuclein Market: Others (2017-2022) & (K Pcs)
Figure 25. Global Alpha Synuclein Sales Market Share by Application (2017-2022)
Figure 26. Global Alpha Synuclein Revenue Market Share by Application in 2021
Figure 27. Alpha Synuclein Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Alpha Synuclein Revenue Market Share by Company in 2021
Figure 29. Global Alpha Synuclein Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Alpha Synuclein Revenue Market Share by Geographic Region in 2021
Figure 31. Global Alpha Synuclein Sales Market Share by Region (2017-2022)
Figure 32. Global Alpha Synuclein Revenue Market Share by Country/Region in 2021
Figure 33. Americas Alpha Synuclein Sales 2017-2022 (K Pcs)
Figure 34. Americas Alpha Synuclein Revenue 2017-2022 ($ Millions)
Figure 35. APAC Alpha Synuclein Sales 2017-2022 (K Pcs)
Figure 36. APAC Alpha Synuclein Revenue 2017-2022 ($ Millions)
Figure 37. Europe Alpha Synuclein Sales 2017-2022 (K Pcs)
Figure 38. Europe Alpha Synuclein Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Alpha Synuclein Sales 2017-2022 (K Pcs)
Figure 40. Middle East & Africa Alpha Synuclein Revenue 2017-2022 ($ Millions)
Figure 41. Americas Alpha Synuclein Sales Market Share by Country in 2021
Figure 42. Americas Alpha Synuclein Revenue Market Share by Country in 2021
Figure 43. United States Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Alpha Synuclein Sales Market Share by Region in 2021
Figure 48. APAC Alpha Synuclein Revenue Market Share by Regions in 2021
Figure 49. China Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Alpha Synuclein Sales Market Share by Country in 2021
Figure 56. Europe Alpha Synuclein Revenue Market Share by Country in 2021
Figure 57. Germany Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Alpha Synuclein Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Alpha Synuclein Revenue Market Share by Country in 2021
Figure 64. Egypt Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Alpha Synuclein Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Alpha Synuclein in 2021
Figure 70. Manufacturing Process Analysis of Alpha Synuclein
Figure 71. Industry Chain Structure of Alpha Synuclein
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...